Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
Background: Hepatic de novo lipogenesis (DNL) is ideally measured in very low-density lipoprotein (VLDL)-triacylglycerol (TAG). In the fasting state, the majority of plasma TAG typically represents VLDL-TAG, however the merits of measuring DNL in total plasma TAG has not been assessed.
Objective: To assess the performance of DNL measured in VLDL-TAG (DNLVLDL-TAG) to that measured in total plasma TAG (DNLPlasma-TAG).
Design: Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Copyright holder:
- Hodson et al.
- Copyright date:
- Rights statement:
- © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record